EC Number |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
---|
3.5.4.B9 | 757890 |
APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death |
Oncotarget |
8 |
54285-54296 |
2017 |
Homo sapiens |
28903341 |
3.5.4.B9 | 755694 |
Biochemical basis of APOBEC3 deoxycytidine deaminase activity on diverse DNA substrates |
ACS Infect. Dis. |
4 |
224-238 |
2018 |
Homo sapiens |
29347817 |
3.5.4.B9 | 758120 |
Catalytic analysis of APOBEC3G involving real-time NMR spectroscopy reveals nucleic acid determinants for deamination |
PLoS ONE |
10 |
e0124142 |
2015 |
Homo sapiens |
25875164 |
3.5.4.B9 | 754123 |
Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA |
J. Biol. Chem. |
290 |
4010-4021 |
2015 |
Homo sapiens |
25542899 |
3.5.4.B9 | 757774 |
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with sDNA |
Nat. Commun. |
9 |
2460 |
2018 |
Homo sapiens |
29941968 |
3.5.4.B9 | 757433 |
Family-wide comparative analysis of cytidine and methylcytidine deamination by eleven human APOBEC proteins |
J. Mol. Biol. |
429 |
1787-1799 |
2017 |
Homo sapiens |
28479091 |
3.5.4.B9 | 721999 |
AID and Apobec3G haphazard deamination and mutational diversity |
Cell. Mol. Life Sci. |
70 |
3089-3108 |
2013 |
Homo sapiens |
23178850 |
3.5.4.B9 | 723071 |
APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis |
J. Virol. |
84 |
7396-7404 |
2012 |
Homo sapiens |
20463080 |
3.5.4.B9 | 734795 |
APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure |
Nucleic Acids Res. |
41 |
6139-6148 |
2013 |
Homo sapiens |
23620282 |
3.5.4.B9 | 723256 |
APOBEC3G DNA deaminase acts processively 3' -> 5' on single-stranded DNA |
Nat. Struct. Mol. Biol. |
13 |
392-399 |
2006 |
Homo sapiens |
16622407 |